Status:
COMPLETED
Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Abdominal Neoplasms
Pelvic Neoplasms
Eligibility:
All Genders
2-20 years
Phase:
PHASE1
Brief Summary
St. Jude Children's Research Hospital is studying ways to make ultrasound images clearer - to be able to see blood vessels, body structures, and tumors better. Ultrasound uses sound waves to create pi...
Eligibility Criteria
Inclusion
- Age: 2-20 years old
- Subject has a known or suspected solid soft tissue tumor in the abdomen or pelvis.
- Subject is scheduled for other imaging or is already scheduled for an ultrasound or has already had adequate imaging performed at an outside institution.
- Subject is able to lie still for the exam without sedation.
Exclusion
- Known or suspected hypersensitivity to albumin, blood or blood products.
- History of open heart surgery, cyanotic congenital heart disease or an axygen saturation of less than 96% as determined by pulse oximetry.
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2004
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00186953
Start Date
June 1 2002
End Date
August 1 2004
Last Update
September 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105